Park, S.U.; Jung, G.U.; Paik, E.K.; Lee, J.-Y.; Cho, D.C.; Chung, H.K.; Jo, H.J.; Jung, S.J.
Azelastine Inhibits Triple-Negative Breast Cancer Cell Viability via an ARF1-Dependent Mechanism. Int. J. Mol. Sci. 2025, 26, 11849.
https://doi.org/10.3390/ijms262411849
AMA Style
Park SU, Jung GU, Paik EK, Lee J-Y, Cho DC, Chung HK, Jo HJ, Jung SJ.
Azelastine Inhibits Triple-Negative Breast Cancer Cell Viability via an ARF1-Dependent Mechanism. International Journal of Molecular Sciences. 2025; 26(24):11849.
https://doi.org/10.3390/ijms262411849
Chicago/Turabian Style
Park, Seon Uk, Gi Ung Jung, Eun Kyung Paik, Jeong-Yeon Lee, Dong Charn Cho, Hee Kyoung Chung, Hang Joon Jo, and Sung Jun Jung.
2025. "Azelastine Inhibits Triple-Negative Breast Cancer Cell Viability via an ARF1-Dependent Mechanism" International Journal of Molecular Sciences 26, no. 24: 11849.
https://doi.org/10.3390/ijms262411849
APA Style
Park, S. U., Jung, G. U., Paik, E. K., Lee, J.-Y., Cho, D. C., Chung, H. K., Jo, H. J., & Jung, S. J.
(2025). Azelastine Inhibits Triple-Negative Breast Cancer Cell Viability via an ARF1-Dependent Mechanism. International Journal of Molecular Sciences, 26(24), 11849.
https://doi.org/10.3390/ijms262411849